| 151 |
21109480 | p53-Reactivating small molecules induce apoptosis and enhance chemotherapeutic cytotoxicity in head and neck squamous cell carcinoma. | 2011 Jan |
1 |
| 152 |
21205083 | Clinical usefulness of mitochondrial transcription factor A expression as a predictive marker in colorectal cancer patients treated with FOLFOX. | 2011 Mar |
1 |
| 153 |
21479885 | Quercetin enhances 5-fluorouracil-induced apoptosis in MSI colorectal cancer cells through p53 modulation. | 2011 Dec |
2 |
| 154 |
21514041 | Gene expression signature of TP53 but not its mutation status predicts response to sequential paclitaxel and 5-FU/epirubicin/cyclophosphamide in human breast cancer. | 2011 Aug 28 |
1 |
| 155 |
21561866 | Interplay between ribosomal protein S27a and MDM2 protein in p53 activation in response to ribosomal stress. | 2011 Jul 1 |
1 |
| 156 |
21629658 | Calbindin 2 (CALB2) regulates 5-fluorouracil sensitivity in colorectal cancer by modulating the intrinsic apoptotic pathway. | 2011 |
1 |
| 157 |
21674128 | DNA damage signaling in response to 5-fluorouracil in three colorectal cancer cell lines with different mismatch repair and TP53 status. | 2011 Sep |
8 |
| 158 |
21709442 | The relative contribution of pro-apoptotic p53-target genes in the triggering of apoptosis following DNA damage in vitro and in vivo. | 2011 Jul 15 |
1 |
| 159 |
21887339 | The chemotherapeutic drug 5-fluorouracil promotes PKR-mediated apoptosis in a p53-independent manner in colon and breast cancer cells. | 2011 |
2 |
| 160 |
22233820 | Relationship between thymidylate synthase and p53 and response to FEC versus taxane adjuvant chemotherapy for breast carcinoma. | 2011 Dec |
2 |
| 161 |
22312705 | MiR-122 increases sensitivity of drug-resistant BEL-7402/5-FU cells to 5-fluorouracil via down-regulation of bcl-2 family proteins. | 2011 Dec |
2 |
| 162 |
19585117 | Synergistic effect of 5-fluorouracil and the flavanoid oroxylin A on HepG2 human hepatocellular carcinoma and on H22 transplanted mice. | 2010 Feb |
1 |
| 163 |
19810096 | Combination of p53 codon 72 polymorphism and inactive p53 mutation predicts chemosensitivity to 5-fluorouracil in colorectal cancer. | 2010 Apr 1 |
9 |
| 164 |
19941080 | p53 genotype predicts response to chemotherapy in patients with squamous cell carcinoma of the esophagus. | 2010 Feb |
1 |
| 165 |
20048189 | TP53 mutations and pathologic complete response to neoadjuvant cisplatin and fluorouracil chemotherapy in resected oral cavity squamous cell carcinoma. | 2010 Feb 10 |
1 |
| 166 |
20107315 | MK-1775, a small molecule Wee1 inhibitor, enhances anti-tumor efficacy of various DNA-damaging agents, including 5-fluorouracil. | 2010 Apr 1 |
1 |
| 167 |
20354524 | Oncogenic KRAS sensitises colorectal tumour cells to chemotherapy by p53-dependent induction of Noxa. | 2010 Apr 13 |
2 |
| 168 |
20367642 | TLR3 induction by anticancer drugs potentiates poly I:C-induced tumor cell apoptosis. | 2010 Jul |
8 |
| 169 |
20368736 | BNIP3 is essential for mediating 6-thioguanine- and 5-fluorouracil-induced autophagy following DNA mismatch repair processing. | 2010 Jun |
2 |
| 170 |
20422012 | The coordinated p53 and estrogen receptor cis-regulation at an FLT1 promoter SNP is specific to genotoxic stress and estrogenic compound. | 2010 Apr 21 |
2 |
| 171 |
20514446 | Implication of necrosis-linked p53 aggregation in acquired apoptotic resistance to 5-FU in MCF-7 multicellular tumour spheroids. | 2010 Jul |
2 |
| 172 |
20633010 | Low-dose 5-fluorouracil induces cell cycle G2 arrest and apoptosis in keloid fibroblasts. | 2010 Dec |
1 |
| 173 |
20638924 | Distribution of TYMS, MTHFR, p53 and MDR1 gene polymorphisms in patients with breast cancer treated with neoadjuvant chemotherapy. | 2010 Oct |
1 |
| 174 |
20704765 | LY294002 may overcome 5-FU resistance via down-regulation of activated p-AKT in Epstein-Barr virus-positive gastric cancer cells. | 2010 Aug 13 |
2 |
| 175 |
20716879 | [Microarray analysis of tumor xenograft model]. | 2010 Aug |
1 |
| 176 |
21036698 | 5-fluorouracil-induced death of Jurkat T-cells--a role for caspases and MCL-1. | 2010 Oct |
2 |
| 177 |
19097688 | Andrographolide enhances 5-fluorouracil-induced apoptosis via caspase-8-dependent mitochondrial pathway involving p53 participation in hepatocellular carcinoma (SMMC-7721) cells. | 2009 Apr 18 |
2 |
| 178 |
19150257 | HCT116 cells deficient in p21(Waf1) are hypersensitive to tyrosine kinase inhibitors and adriamycin through a mechanism unrelated to p21 and dependent on p53. | 2009 Mar 1 |
2 |
| 179 |
19155291 | Limits to thymidylate synthase and TP53 genes as predictive determinants for fluoropyrimidine sensitivity and further evidence for RNA-based toxicity as a major influence. | 2009 Feb 1 |
2 |
| 180 |
19270508 | Modulation of thymidilate synthase and p53 expression by HDAC inhibitor vorinostat resulted in synergistic antitumor effect in combination with 5FU or raltitrexed. | 2009 May |
1 |
| 181 |
19542220 | Mirk regulates the exit of colon cancer cells from quiescence. | 2009 Aug 21 |
1 |
| 182 |
19605487 | Hepatitis C virus core protein and cellular protein HAX-1 promote 5-fluorouracil-mediated hepatocyte growth inhibition. | 2009 Oct |
4 |
| 183 |
19661313 | Scutellarin sensitizes drug-evoked colon cancer cell apoptosis through enhanced caspase-6 activation. | 2009 Aug |
6 |
| 184 |
19723892 | Prostate-derived factor--a novel inhibitor of drug-induced cell death in colon cancer cells. | 2009 Sep |
1 |
| 185 |
19731257 | The p53-mediated sensitivity of cancer cells to chemotherapeutic agents is conditioned by the status of the retinoblastoma protein. | 2009 Nov |
2 |
| 186 |
19923910 | The combination of 5-fluorouracil plus p53 pathway restoration is associated with depletion of p53-deficient or mutant p53-expressing putative colon cancer stem cells. | 2009 Nov |
2 |
| 187 |
19954513 | Identification of colorectal cancer patients with tumors carrying the TP53 mutation on the codon 72 proline allele that benefited most from 5-fluorouracil (5-FU) based postoperative chemotherapy. | 2009 Dec 2 |
7 |
| 188 |
17637740 | Cytotoxic drug-induced, p53-mediated upregulation of caspase-8 in tumor cells. | 2008 Jan 31 |
2 |
| 189 |
17698398 | Cyr61/CCN1 is a tumor suppressor in human hepatocellular carcinoma and involved in DNA damage response. | 2008 |
2 |
| 190 |
17982488 | Wild-type p53 and p73 negatively regulate expression of proliferation related genes. | 2008 Apr 17 |
1 |
| 191 |
18191509 | Innovative bola-surfactant niosomes as topical delivery systems of 5-fluorouracil for the treatment of skin cancer. | 2008 Apr 2 |
1 |
| 192 |
18325917 | p53 status and efficacy of primary anthracyclines/alkylating agent-based regimen according to breast cancer molecular classes. | 2008 Jul |
1 |
| 193 |
18357466 | Prognostic role of p53 codon 72 polymorphism in gastric cancer patients treated with fluorouracil-based adjuvant chemotherapy. | 2008 Oct |
5 |
| 194 |
18377724 | CSE1L/CAS, a microtubule-associated protein, inhibits taxol (paclitaxel)-induced apoptosis but enhances cancer cell apoptosis induced by various chemotherapeutic drugs. | 2008 Mar 31 |
1 |
| 195 |
18497562 | Resveratrol displays converse dose-related effects on 5-fluorouracil-evoked colon cancer cell apoptosis: the roles of caspase-6 and p53. | 2008 Aug |
4 |
| 196 |
18497992 | Mechanism of resistance to chemoradiation in p53 mutant human colon cancer. | 2008 Jun |
2 |
| 197 |
18498133 | Pathway based analysis of SNPs with relevance to 5-FU therapy: relation to intratumoral mRNA expression and survival. | 2008 Aug 1 |
1 |
| 198 |
18600534 | Functional inactivity and mutations of p53 differentially affect sensitivity to 5-fluorouracil and antifolate inhibitors of thymidylate synthase (TS) by altering TS levels in colorectal cancer cells. | 2008 Jun |
1 |
| 199 |
18779317 | p53 regulates Toll-like receptor 3 expression and function in human epithelial cell lines. | 2008 Nov |
3 |
| 200 |
18834353 | Effect of Bupleuri Radix extracts on the toxicity of 5-fluorouracil in HepG2 hepatoma cells and normal human lymphocytes. | 2008 Oct |
1 |